Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/52565, first published .
Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial

Naokatsu Ando   1 , MD, PhD ;   Daisuke Mizushima   1 , MD, PhD ;   Yosuke Shimizu   2 , MAS ;   Yukari Uemura   2 , PhD ;   Misao Takano   1 , PhD ;   Morika Mitobe   3 , BPharm ;   Kai Kobayashi   3 , DVM ;   Hiroaki Kubota   3 , PhD ;   Hirofumi Miyake   3 , PhD ;   Jun Suzuki   3 , PhD ;   Kenji Sadamasu   3 , PhD ;   Takato Nakamoto   1 , MD ;   Takahiro Aoki   1 , MD, PhD ;   Koji Watanabe   1 , MD, PhD ;   Shinichi Oka   1 , MD, PhD ;   Hiroyuki Gatanaga   1 , MD, PhD

1 AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan

2 Biostatistics Section, Department of Data Science, National Center for Global Health and Medicine, Tokyo, Japan

3 Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan

Corresponding Author:

  • Naokatsu Ando, MD, PhD
  • AIDS Clinical Center
  • National Center for Global Health and Medicine
  • 1-21-1 Toyama
  • Tokyo, 1628655
  • Japan
  • Phone: 81 332027181
  • Fax: 81 332084244
  • Email: nandou@hosp.ncgm.go.jp